Cardiac resynchronization therapy defibrillator

From WikiCover

On December 28, 2007, Boston Scientific announced CE Mark approval for its Livian cardiac resynchronization therapy defibrillator (CRT-D), which treats heart failure and helps protect patients at risk of sudden cardiac death. The Livian CRT-D is specifically designed to monitor heartbeats in heart failure patients and deliver small electrical impulses that may improve the heart's pumping ability.

The Livian CRT-D, which is available in high-energy and standard-energy models, enables clinicians to customize therapy based on a patient's individual needs. The implantable device uses Boston Scientific proprietary technology -- built on years of clinical research -- and is designed to improve a patient's response to cardiac resynchronization therapy. Livian also offers clinicians technology to help manage heart failure patients with frequent atrial arrhythmias.